Phase 3 Liver Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) based on specific international guidelines used by liver disease specialists.
• People who have at least one tumor that can be clearly measured using established liver cancer assessment methods.
• People whose liver cancer is classified as Barcelona Clinic Liver Cancer Stage C (an advanced stage of liver cancer).
• People whose general physical ability and daily functioning falls within a certain range on a standard medical scale (rated 0 to 2, meaning able to carry out at least some daily activities).
• People who have not previously received any treatment for this condition.
• People who either have no liver scarring (cirrhosis), or whose cirrhosis is mild and classified as Child-Pugh class A (a measure of liver function).
• People whose cancer cannot be treated by surgery, targeted heat or cold therapies, or any other treatment intended to cure the disease.
• People with hepatitis B are allowed to join, regardless of their viral load level, provided they are also receiving appropriate antiviral medication at the same time.
• People whose blood test results meet the following minimum standards: sufficient red blood cell levels, acceptable liver and kidney function markers, normal clotting measures, and adequate white blood cell counts (confirm specific values with the trial site).
• People who are able to understand the trial and are willing to sign a written consent form.

Who may not be able to join:

• People who show signs of serious liver failure, such as fluid build-up in the abdomen, bleeding in the digestive tract, or confusion caused by liver disease.
• People with a known history of HIV.
• People who have previously received an organ transplant.
• People with a known or suspected allergy to any of the medications used in this trial.
• People who have irregular heart rhythms that require medication to control.
• People who have evidence of a condition that causes abnormal or excessive bleeding.
• People who have experienced significant bleeding in the digestive tract within the 30 days before joining the trial.
• People who have tumors in the brain or central nervous system, including cancer that has spread to the brain.

Important: Always verify eligibility with the trial site directly before applying.